Tumor angiogenesis is an independent prognostic indicator in primary breast carcinoma

Clinical importance of tumor angiogenesis, especially its significance as a prognostic indicator, was examined in 125 primary breast‐cancer patients. The grade of neovascularization was assessed by the vessel density which was obtained by immunocytochemical staining for factor VIII antigen. Postoperative survey demonstrated that the vessel density is a statistically significant predictor of relapse‐free survival (median follow‐up period: 62 months). Patients with over 100 counts of factor‐VIII antigen‐positive cells per 200 x field in the most active areas of neovascularization showed significantly poorer prognosis than those with less than 100 counts. The prognostic value of the vessel density was also confirmed by another evaluation method using immunocytochemical staining to CD‐31 which is a platelet/endothelial cell adhesion molecule. A significant difference in relapse‐free survival rate was shown between patients having higher counts of CD‐31 positive cells and those having lower counts. Breakdown analysis stratified by nodal status showed that the vessel density was a significant prognostic indicator in node‐negative and node‐positive patients. Multivariate analysis indicated that the vessel density is an independent prognostic indicator in primary breast‐cancer patients.

[1]  F Pozza,et al.  Tumor angiogenesis: a new significant and independent prognostic indicator in early-stage breast carcinoma. , 1992, Journal of the National Cancer Institute.

[2]  A. Harris,et al.  Angiogenesis, assessed by platelet/endothelial cell adhesion molecule antibodies, as indicator of node metastases and survival in breast cancer , 1992, The Lancet.

[3]  K. Kuroi,et al.  Prognostic significance of co-expression of c-erbB-2 oncoprotein and epidermal growth factor receptor in breast cancer patients. , 1992, American journal of surgery.

[4]  A. Lee,et al.  Microvessel quantitation and prognosis in invasive breast carcinoma. , 1992, Human pathology.

[5]  P Boracchi,et al.  Human breast cancer: prognostic significance of the c-erbB-2 oncoprotein compared with epidermal growth factor receptor, DNA ploidy, and conventional pathologic features. , 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[6]  R Bicknell,et al.  Heterogeneity of vascular endothelial cells with relevance to diagnosis of vascular tumours. , 1992, Journal of clinical pathology.

[7]  A. Harris,et al.  Novel growth regulatory factors and tumour angiogenesis. , 1991, European journal of cancer.

[8]  J. Folkman What is the evidence that tumors are angiogenesis dependent? , 1990, Journal of the National Cancer Institute.

[9]  D. Hanahan,et al.  Induction of angiogenesis during the transition from hyperplasia to neoplasia , 1989, Nature.

[10]  M. Toi,et al.  Immunocytochemical and biochemical analysis of epidermal growth factor receptor expression in human breast cancer tissues: Relationship to estrogen receptor and lymphatic invasion , 1989, International journal of cancer.

[11]  W. McGuire,et al.  Current status of estrogen and progesterone receptors in breast cancer , 1977, Cancer.